Enantiomeric determination of amlodipine in human plasma by liquid chromatography coupled to tandem mass spectrometry

Journal of Biochemical and Biophysical Methods

Volumn 54, Issue 1-3, 2002, Pages 357-368

  Streel, B ^a   Laine C ^a   Zimmer, C ^a   Sibenaler, R ^b   Ceccato, A ^a  

^a Galephar MF   (Belgium)

^b SMB Laboratoires   (Belgium)

Author keywords

1 acid glycoprotein; Amlodipine; Enantiomer separation; Solid phase extraction; Tandem mass spectrometry

Indexed keywords

ACETIC ACID; AMLODIPINE; AMMONIUM ACETATE; BUFFER; ION; METHANOL; OROSOMUCOID; PROPANOL; PROPRANOLOL; SILICON DIOXIDE; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; CHEMICAL PARAMETERS; CHIRAL CHROMATOGRAPHY; COLUMN CHROMATOGRAPHY; DRUG ANALYSIS; ENANTIOMER; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; STANDARD; STEREOCHEMISTRY; TANDEM MASS SPECTROMETRY;

AMLODIPINE; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEREOISOMERISM;

EID: 0037207253     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(02)00133-1     Document Type: Article

References (44)

1. Meredith P.A., Elliott H.L. Clinical pharmacokinetics of amlodipine. Clin. Pharmacokinet. 22:1992;22-31.
2. Murdoch D., Heel R.C. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs. 41:1991;478-505.
3. Arrowsmith J.E., Campbell F., Cross E., Stubbs J.K., Burges R.A., Gardiner D.G.et al. Long-acting dihydropyridine calcium antagonists: 1. 2-Alkylmethyl derivatives incorporating basic substituents. J. Med. Chem. 29:1986;1696-1702.
4. Goldmann S., Stoltefuss J., Born L. Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction. J. Med. Chem. 35:1992;3341-3344.
5. Pandya K.K., Satia M., Gandhi T.P., Modi I.A., Modi R.I., Chakravarthy B.K. Detection and determination of total amlodipine by high-performance thin-layer chromatography: a useful technique for pharmacokinetics studies. J. Chromatogr., B. 667:1995;315-320.
6. Beresford A.P., Macrae P.V., Stopher D.A., Wood B.A. Analysis of amlodipine in human plasma by gas chromatography. J. Chromatogr. 420:1987;178-183.
7. Monkman S.C., Ellis J.S., Cholerton S., Thomason J.M., Seymour R.A., Idle J.R. Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluid. J. Chromatogr., B. 678:1996;360-364.
8. Shimooka K., Sawada Y., Tatematsu H. Analysis of amlodipine in serum by a sensitive high-performance liquid chromatographic method with amperometric detection. J. Pharm. Biomed. Anal. 7:1989;1267-1272.
9. Josefsson M., Zackrisson A.-L., Norlander B. Sensitive high-performance liquid chromatographic analysis of amlodipine in human plasma with amperometric detection and a single-step solid-phase sample preparation. J. Chromatogr., B. 672:1995;310-313.
10. Yasuda T., Tanaka M., Iba K. Quantitative determination of amlodipine in serum by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J. Mass Spectrom. 31:1996;879-884.
11. Scharpf F., Riedel K.-D., Laufen H., Leitold M. Enantioselective gas chromatographic assay with electron-capture detection for amlodipine in biological samples. J. Chromatogr., B. 655:1994;225-233.
12. Vandenbosch C., Massart D.L., Lindner W. Evaluation of six chiral stationary phases in LC for their selectivity towards drug enantiomers. J. Pharm. Biomed. Anal. 10:1992;895-908.
13. Soons P.A., Roosemalen M.C.M., Breimer D.D. Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma. J. Chromatogr. 528:1990;343-356.
14. Sakamoto T., Ohtake Y., Itoh M., Tabata S., Kuriki T., Uno K. Determination of felodipine enantiomers using chiral stationary phase liquid chromatography and gas chromatography/mass spectrometry, and the study of their pharmacokinetic profiles in human and dog. Biomed. Chromatogr. 7:1993;99-103.
15. Yamaguchi M., Yamashita K., Aoki I., Tabata T., Hirai S., Yashiki T. Determination of manidipine enantiomers in human serum using chiral chromatography and column-switching liquid chromatography. J. Chromatogr. 575:1992;123-129.
16. Dru J.D.-Y., Hsieh J.Y.-K., Matuszewski B.K., Dobinska M.R. Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection. J. Chromatogr., B. 666:1995;259-267.
17. Fischer C., Schonberger F., Mück W., Heuck K., Eichelbaum M. Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with stable isotope technique. J. Pharm. Sci. 82:1993;244-250.
18. Heinig R., Muschalek V., Ahr G. Determination of the enantiomers of nisoldipine in human plasma using high-performance liquid chromatography on a chiral stationary phase and gas chromatography with mass-selective detection. J. Chromatogr., B. 655:1994;286-292.
19. Zimmer D., Muschalek V. Enantioselective assay for the determination of nisoldipine in dog, rat and mouse plasma by chiral microbore high-performance liquid chromatography combined with gas chromatography-mass spectrometry. J. Chromatogr., A. 666:1994;241-248.
20. Marques M.P., Santos N.A.G., Coelho E.B., Bonato and P.S., Lanchote V.L. Enantioselective assay of nisoldipine in human plasma by chiral high-performance liquid chromatography combined with gas chromatographic-mass spectrometry: applications to pharmacokinetics. J. Chromatogr., B. 762:2001;87-95.
21. Mück W., Bode H. Bioanalytics of nimodipine - an overview of methods. Pharmazie. 49:1992;130-139.
22. Mück W.M. Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr., A. 712:1995;45-53.
23. Lindmark B., Ahnoff M., Persson B.A. Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry. J. Pharm. Biomed. Anal. 27:2002;489-495.
24. Tokuma Y., Noguchi H. Stereoselective pharmacokinetics of dihydropyridine calcium antagonists. J. Chromatogr., A. 694:1995;181-193.
25. Luksa J., Josic Dj., Kremser M., Kopitar Z., Milutinovic S. Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration. J. Chromatogr., B. 703:1997;185-193.
26. Josefsson M., Norlander B. Coupled-column chromatography on a Chiral AGP phase for determination of amlodipine enantiomers in human plasma: an HPLC assay with electrochemical detection. J. Pharm. Biomed. Anal. 15:1996;267-277.
27. Luksa J., Josic Dj., Podobnik B., Furlan B., Kremser M. Semi-preparative chromatographic purification of the enantiomers S-(-)-amlodipine and R-(+)-amlodipine. J. Chromatogr., B. 693:1997;367-375.
28. De Lorenzi E., Fell A.F., Caccialanza G., Massolini G., Kitsos M. Design of chiral LC separations for calcium antagonists on alpha 1-acid glycoprotein and ovomucoid columns. J. Pharm. Biomed. Anal. 10:1992;909-915.
29. Fu Q., Matsunaga H., Haginaka J. Resolution of dihydropyridine calcium antagonist enantiomers using HPLC with ovoglycoprotein as chiral stationary phase. Anal. Sci. 17:2001;897-900.
30. Laufen H., Leitold H. Enantioselective disposition of oral amlodipine in healthy volunteers. Chirality. 6:1994;531-536.
31. Rask H.S., Angelo H.R., Christensen H.R. Enantioselective determination of isradipine in human serum using chiral stationary phase liquid chromatography and gas chromatography with nitrogen selective detection. Chirality. 10:1998;808-812.
32. Iwaoka T., Inotsume N., Inoue J., Naomi S., Okamoto Y., Higuchi S.et al. Determination of (+)- and (-)-nicardipine concentrations in human serum and their correlation with the antihypertensive effect oral administration of racemic nicardipine. Eur. J. Clin. Pharmacol. 48:1995;34-349.
33. Ceccato A., Toussaint B., Chiap P., Hubert Ph., Crommen J. Automated sample preparation techniques for the determination of drug enantiomers in biological fluids using liquid chromatography with chiral stationary phases. Enantiomer. 4:1999;305-315.
34. Henion J., Brewer E., Rule G. Sample preparation for LC/MS/MS: analyzing biological and environmental samples. Anal. Chem. 70:1998;650A-656A.
35. Chankvetadze B., Chankvetadze L., Sidamonidze S., Yashima E., Okamoto Y. High performance liquid chromatography enantioseparation of chiral pharmaceuticals using tris(chloro-methylphenylcarbamate)s of cellulose. J. Pharm. Biomed. Anal. 14:1996;1295-1303.
36. Narayanan S.R. Immobilized proteins as chromatographic supports for chiral resolution. J. Pharm. Biomed. Anal. 10:1992;251-262.
37. Hermansson J., Grahn A. Optimization of the separation of enantiomers of basic drugs. Retention mechanisms and dynamic modification of the chiral bonding properties on an alpha 1-acid glycoprotein column. J. Chromatogr., A. 694:1995;57-69.
38. Maurer H.H. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J. Chromatogr., B. 713:1998;3-25.
39. Ceccato A., Vanderbist F., Pabst J.-Y., Streel B. Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr., B. 748:2000;65-76.
40. Niessen W.H.A. Advances in instrumentation in liquid chromatography-mass spectrometry and related liquid-introduction techniques. J. Chromatogr., A. 794:1998;407-435.
41. de Hoffman E., Charrette J., Stroobant V. Masson Spectrométrie de Masse. 1994;103.
42. Brewer E., Henion J. Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies. J. Pharm. Sci. 87:1998;395-402.
43. Buick A.R., Doig M.V., Jeal S.C., Land G.S., MacDowall R.D. Method validation in the bioanalytical laboratory. J. Pharm. Biomed. Anal. 8:1990;629-637.
44. Guidance for industry, bionalytical method validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDEC), Center for Veterinary Medicine (CVM), May 2001.